Valuation Amarin Corporation plc

Stocks

Market Closed - Nasdaq Other stock markets 21:00:00 22/07/2026 BST			5-day change	1st Jan Change
13.71 ^USD	-1.58%		-5.19%	-1.76%

07-02	European Equities Traded in the US as American Depositary Receipts Rise Sharply in Thursday Trading	MT
06-30	Amarin Corporation plc Reaffirms the Proven Guideline-Recommended Role of Vascepa (Icosapent Ethyl) in an Evolving Triglyceride Treatment Landscape	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	1,333	488.6	355.2	199.5	290.2	287.5	-	-
Change	-	-63.35%	-27.3%	-43.84%	45.45%	-0.92%	-	-
Enterprise Value (EV) ¹	1,114	270.4	156	78.46	155.5	113.6	100	95.49
Change	-	-75.72%	-42.33%	-49.69%	98.19%	-26.93%	-11.99%	-4.51%
P/E	169x	-4.65x	-5.8x	-2.43x	-155x	-457x	-686x	-343x
PBR	2x	0.82x	0.64x	0.41x	-	-	-	-
PEG	-	0x	0.1x	-0.1x	1.6x	6.9x	20.6x	-3x
Capitalization / Revenue	2.29x	1.32x	1.16x	0.87x	1.36x	1.62x	1.81x	2.05x
EV / Revenue	1.91x	0.73x	0.51x	0.34x	0.73x	0.64x	0.63x	0.68x
EV / EBITDA	44.9x	-5.69x	-2.31x	-0.86x	-3.1x	-4.44x	-4.85x	-3.39x
EV / EBIT	46x	-3.64x	-2.31x	-0.85x	-3.1x	-4.44x	-4.85x	-3.38x
EV / FCF	-	-	-	-	-	-	-	-
FCF Yield	-	-	-	-	-	-	-	-
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	0.4	-5.2	-3	-4	-0.09	-0.03	-0.02	-0.04
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	583.2	369.2	306.9	228.6	213.6	177.8	158.8	140.2
EBITDA ¹	24.81	-47.5	-67.43	-91.7	-50.17	-25.57	-20.61	-28.21
EBIT ¹	24.22	-74.26	-67.59	-91.8	-50.17	-25.58	-20.61	-28.21
Net income ¹	7.729	-105.8	-59.11	-82.18	-38.8	-12.75	-9.038	-16.28
Net Debt ¹	-219.5	-218.2	-199.3	-121	-134.7	-173.9	-187.5	-192
Reference price ²	67.40	24.20	17.40	9.70	13.96	13.71	13.71	13.71
Nbr of stocks (in thousands)	19,781	20,191	20,415	20,567	20,793	20,969	-	-
Announcement Date	01/03/22	01/03/23	29/02/24	12/03/25	25/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
AMARIN CORPORATION PLC	-457x	0.64x	-4.44x	-	287M
WUXI APPTEC CO., LTD.	20.83x	6.36x	13.92x	1.53%	55.27B
ARGENX SE	32.72x	8.17x	25.61x	0.05%	54.15B
INSMED INCORPORATED	-41.75x	13.26x	-39.07x	-.--%	23.11B
BIONTECH SE	-18.34x	4.38x	-7.67x	-.--%	23.22B
WUXI BIOLOGICS (CAYMAN) INC.	25.44x	5.01x	13.23x	-.--%	20.33B
GENMAB A/S	24.96x	4.84x	15.73x	-.--%	17.91B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	-612.56x	37.5x	-1557.05x	-.--%	15.76B
PHARMAESSENTIA CORPORATION	45.31x	18.35x	47.24x	0.08%	15B
EXELIXIS, INC.	17.3x	5.01x	11.68x	-.--%	13.82B
Average	-96.31x	10.35x	-148.08x	0.18%	23.89B
Weighted average by Cap.	-26.67x	9.74x	-92.30x	0.37%